2N. Katakami,Y. Yamasaki,R. Hayaishi-Okano,K. Ohtoshi,H. Kaneto,M. Matsuhisa,K. Kosugi,M. Hori. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes[J] 2004,Diabetologia(11):1906～1913
二级参考文献5
1Zimmet P, McCarty D. The NIDDM epidemic: global estimates and projections-a look into the crystal ball. IDF Bulletin, 1995, 40: 8-16.
2Zimmerman BR. Sulfonylureas. Endocriol Metab Clin North Am,1997,26:51-1512.
3Gregorio F, Ambrosi F, Filpponi P, et al. Glucose modulates the amount, but not the kinetics, of insulin release by sulfonylureas. J Diabetes Complications. 1994, 8: 204-212.
4Guillausseau PJ. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice.Diabetes Metab, 2003, 29:79-18.
